-- アクセリス・テクノロジーズ(ACLS)の株価は、月曜午後の取引で8.6%上昇した。これは、B.ライリーが同社株の投資判断を「中立」から「買い」に引き上げ、目標株価を91ドルから150ドルに引き上げたことが要因。 出来高は約80万9000株で、1日の平均出来高とほぼ同水準だった。
Price: $128.52, Change: $+9.79, Percent Change: +8.25%
-- アクセリス・テクノロジーズ(ACLS)の株価は、月曜午後の取引で8.6%上昇した。これは、B.ライリーが同社株の投資判断を「中立」から「買い」に引き上げ、目標株価を91ドルから150ドルに引き上げたことが要因。 出来高は約80万9000株で、1日の平均出来高とほぼ同水準だった。
Price: $128.52, Change: $+9.79, Percent Change: +8.25%
Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.
SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.
Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.